[node:field-first-name] [node:field-last-name]


Board Certifications and Licenses


Research Interests

Public Health Policy
Outcomes Research

Selected Publications

Schumock GT, Li EC, Wiest MD, Suda KJ, Stubbings J, Matusiak LM, Hunkler RJ, Vermeulen LC.  National trends in prescription drug expenditures and projections for 2017. Am J Health Syst Pharm. 2017 May 22. pii: ajhp170164. doi: 10.2146/ajhp170164.

Zelenetz AD, Ahmed I, Braud EL, Cross JD, Davenport-Ennis N, Dickinson BD, Goldberg SE, Gottlieb S, Johnson PE, Lyman GH, Markus R, Matulonis UA, Reinke D, Li EC, DeMartino J, Larsen JK, Hoffman JM. NCCN Biosimilars White Paper: Regulatory, Scientific, and Patient Safety Perspectives. J Natl Comp Canc Netw. 2011;9[Suppl 4]:S1-S22.

Li EC, DeMartino JM. Preliminary Report: The Development of the NCCN Comparative Therapeutic Index as a Clinical Evaluative Process for Existing Data in Oncology. J Natl Comp Canc Netw. 2010;8[Suppl 5]:S1-S10.

Johnson PE, Dahlman G, Eng K, Garg R, Gottlieb S, Hoffman JM, Howell P, Jahanzeb M, Johnson S, Mackler E, Rubino M, Sarokhan B, Stewart FM, Tyler T, Vose JM, Weinstein S, Li EC, DeMartino J. NCCN Oncology Risk Evaluation and Mitigation Strategies White Paper: Recommendations for Stakeholders. J Natl Comp Canc Netw. 2010;8[Suppl 7]:S7-S27.


Other Scholarly Activity

Google Scholar Profile:


[node:field-first-name] [node:field-last-name]


Portland Campus

Pharmacy Building
On Leave